HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Mankoff, D. A. Articles by Krohn, K. A. Search for Related Content PubMed PubMed Citation Articles by Mankoff, D. A. Articles by Krohn, K. A.

Tumor Receptor Imaging

¹ Division of Nuclear Medicine, University of Washington, Seattle, Washington; ² Department of Medicine, University of Washington, Seattle, Washington; and ³ Seattle Cancer Care Alliance, Seattle, Washington

Correspondence: For correspondence or reprints contact: David A. Mankoff, Radiology, G-2100, Seattle Cancer Care Alliance, 825 Eastlake Ave. East, P.O. Box 19023, Seattle, WA 98109-1023. E-mail: dam{at}u.washington.edu

Tumor receptors play an important role in carcinogenesis and tumor growth and have been some of the earliest targets for tumor-specific therapy, for example, the estrogen receptor in breast cancer. Knowledge of receptor expression is key for therapy directed at tumor receptors and traditionally has been obtained by assay of biopsy material. Tumor receptor imaging offers complementary information that includes evaluation of the entire tumor burden and characterization of the heterogeneity of tumor receptor expression. The nature of the ligand–receptor interaction poses a challenge for imaging—notably, the requirement for a low molecular concentration of the imaging probe to avoid saturating the receptor and increasing the background because of nonspecific uptake. For this reason, much of the work to date in tumor receptor imaging has been done with radionuclide probes. In this overview of tumor receptor imaging, aspects of receptor biochemistry and biology that underlie tumor receptor imaging are reviewed, with the estrogen–estrogen receptor system in breast cancer as an illustrative example. Examples of progress in radionuclide receptor imaging for 3 receptor systems—steroid receptors, somatostatin receptors, and growth factor receptors—are highlighted, and recent investigations of receptor imaging with other molecular imaging modalities are reviewed.

Key Words: tumors • receptors • imaging

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.